Literature DB >> 1828759

Denaturing gradient gel electrophoretic analysis of minisatellite alleles.

A G Uitterlinden1, J Vijg.   

Abstract

By two-dimensional DNA fingerprinting, an electrophoretic method which combines separation according to size with separation in a denaturing gradient, virtually all minisatellite sequences detected with a minisatellite core probe can be resolved (Uitterlinden et al., Proc. Natl. Acad. Sci. USA 1989, 86, 2742-2746). To investigate the electrophoretic behavior in denaturing gradient gels of allelic restriction fragments containing minisatellite sequences, we analyzed alleles of the two highly polymorphic minisatellite loci D7S22 and D2S44. The results obtained indicate that for these loci, depending on the restriction enzyme used to digest genomic DNA, alleles of different sizes migrate to regions of similar denaturant concentration, i.e. to isothermal positions in the denaturing gradient. Denaturing gradient gel electrophoresis also allows for the discrimination of restriction fragments which are the result of the presence of internal recognition sites in the minisatellite and, therefore, to distinguish between VNTR and restriction site polymorphisms.

Mesh:

Substances:

Year:  1991        PMID: 1828759     DOI: 10.1002/elps.1150120104

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  3 in total

Review 1.  Two-dimensional DNA typing: A cost-effective way of analyzing complex mixtures of DNA fragments for sequence variations.

Authors:  J Vijg
Journal:  Mol Biotechnol       Date:  1995-12       Impact factor: 2.695

2.  Linkage analysis by two-dimensional DNA typing.

Authors:  G J te Meerman; E Mullaart; M A van der Meulen; J H den Daas; B Morolli; A G Uitterlinden; J Vijg
Journal:  Am J Hum Genet       Date:  1993-12       Impact factor: 11.025

3.  Genome scanning of breast cancers by two-dimensional DNA typing.

Authors:  A M Verwest; W J de Leeuw; A C Molijn; T I Andersen; A L Börresen; E Mullaart; A G Uitterlinden; J Vijg
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.